OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
606258

Charm Care Corp

Healthcare Facilities & ServicesVerified

Charm Care Corp has a liquidity position that is characterized by a current ratio of 0.93, indicating that its current liabilities exceed its current assets. The company's liquidity is further constrained by a negative net cash position after subtracting total debt, which is a key flag in its risk assessment. Despite this, the company maintains a relatively low debt-to-equity ratio of 0.65, suggesting a conservative capital structure. In terms of profitability, Charm Care Corp demonstrates a return on equity (ROE) of 14.2%, which is a strong indicator of its ability to generate profits from shareholders' equity. The company's return on assets (ROA) of 5.6% also suggests a moderate level of efficiency in utilizing its assets to generate earnings. These metrics are in line with the industry's preferred metrics for evaluating healthcare services and equipment firms. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This concentration may expose the company to higher risks if the segment or region experiences a downturn. Charm Care Corp's growth trajectory is reflected in its capital expenditures, which amounted to -4.84 billion JPY, indicating a reduction in investment in long-term assets. The company's free cash flow is negative at -1.69 billion JPY, which may limit its ability to fund future growth initiatives without external financing. The risk assessment for Charm Care Corp highlights a medium liquidity risk, primarily due to its negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution potential reported in the basic shares outstanding. The risk assessment does not indicate any major adjustments or dilution sources in the valuation. Recent events and disclosures for Charm Care Corp include analyst estimates that are uniformly set at 1,710.00 JPY, with a mean recommendation of 2.00, indicating a neutral stance from analysts. There are no recent filings or transcripts that suggest significant changes in the company's operations or strategy.

30-day price · 6062(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyCharm Care Corp
Ticker6062.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Charm Care Corp provides healthcare services and equipment, primarily operating in the biotechnology sector.

Classification. Charm Care Corp is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a classification confidence of 0.92.

Charm Care Corp has a liquidity position that is characterized by a current ratio of 0.93, indicating that its current liabilities exceed its current assets. The company's liquidity is further constrained by a negative net cash position after subtracting total debt, which is a key flag in its risk assessment. Despite this, the company maintains a relatively low debt-to-equity ratio of 0.65, suggesting a conservative capital structure. In terms of profitability, Charm Care Corp demonstrates a return on equity (ROE) of 14.2%, which is a strong indicator of its ability to generate profits from shareholders' equity. The company's return on assets (ROA) of 5.6% also suggests a moderate level of efficiency in utilizing its assets to generate earnings. These metrics are in line with the industry's preferred metrics for evaluating healthcare services and equipment firms. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This concentration may expose the company to higher risks if the segment or region experiences a downturn. Charm Care Corp's growth trajectory is reflected in its capital expenditures, which amounted to -4.84 billion JPY, indicating a reduction in investment in long-term assets. The company's free cash flow is negative at -1.69 billion JPY, which may limit its ability to fund future growth initiatives without external financing. The risk assessment for Charm Care Corp highlights a medium liquidity risk, primarily due to its negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution potential reported in the basic shares outstanding. The risk assessment does not indicate any major adjustments or dilution sources in the valuation. Recent events and disclosures for Charm Care Corp include analyst estimates that are uniformly set at 1,710.00 JPY, with a mean recommendation of 2.00, indicating a neutral stance from analysts. There are no recent filings or transcripts that suggest significant changes in the company's operations or strategy.
Key takeaways
  • Charm Care Corp has a strong return on equity (14.2%) but a moderate return on assets (5.6%), indicating efficient use of equity but less so of total assets.
  • The company's liquidity position is weak, with a current ratio of 0.93 and a negative net cash position after subtracting total debt.
  • Capital expenditures are negative, suggesting a reduction in investment in long-term assets, which may affect future growth.
  • Analysts have a neutral stance on the company, with a mean recommendation of 2.00 and a uniform price target of 1,710.00 JPY.
  • The company's revenue is concentrated in a single segment, which may increase its exposure to sector-specific risks.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$46.67B
Gross profit$7.24B
Operating income$4.04B
Net income$2.94B
R&D
SG&A
D&A
SBC
Operating cash flow$3.73B
CapEx-$4.84B
Free cash flow-$1.69B
Total assets$52.41B
Total liabilities$31.74B
Total equity$20.68B
Cash & equivalents$9.15B
Long-term debt$13.45B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$20.68B
Net cash-$4.30B
Current ratio0.9
Debt/Equity0.7
ROA5.6%
ROE14.2%
Cash conversion1.3%
CapEx/Revenue-10.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
Metric6062Activity
Op margin8.7%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin6.3%8.6% medp25 6.3% · p75 12.4%below median
Gross margin15.5%28.8% medp25 28.8% · p75 28.8%bottom quartile
CapEx / revenue-10.4%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity65.0%71.3% medp25 60.7% · p75 71.3%below median
Observations
IR observations
Mean price target1,710.00 JPY
Median price target1,710.00 JPY
High price target1,710.00 JPY
Low price target1,710.00 JPY
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate105.85 JPY
Last actual EPS89.89 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 18:31 UTC#945bc0bb
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:32 UTCJob: 73102e77